ArticleBioinformation2026
Bispectral index-guided versus standard anaesthesia monitoring for intraoperative awareness prevention.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although bispectral index (BIS) monitoring provides an objective measure of hypnotic depth, its routine use to prevent awareness remains debated due to conflicting evidence and cost considerations. Therefore, it is of interest to evaluate BIS-guided versus clinically guided sevoflurane anaesthesia in 200 adults undergoing elective surgery over 60 minutes. No definite intraoperative awareness occurred in either group, confirmed by modified Brice interviews up to 30 days postoperatively. BIS monitoring reduced sevoflurane consumption by 24% (1.7 ± 0.4 vs 2.2 ± 0.5 MAC-hours; p < 0.001) and accelerated extubation (7.9 ± 2.3 vs 10.8 ± 3.1 min; p < 0.001) and PACU discharge (46.2 ± 11.8 vs 56.9 ± 14.7 min; p < 0.001). It also provided greater haemodynamic stability, with lower MAP variability (11.4 ± 3.9% vs 16.8 ± 5.6%; p < 0.001). BIS monitoring optimizes anaesthetic delivery and recovery efficiency without lowering awareness incidence compared to vigilant clinical monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.